Fineline Cube

Follow:
14483 Articles
Huadong Medicine's Elahere (Mirvetuximab Soravtansine) Approved by NMPA for Ovarian Cancer Treatment
CompanyDrug

Huadong Medicine’s Elahere (Mirvetuximab Soravtansine) Approved by NMPA for Ovarian Cancer Treatment

MicuRx Pharmaceuticals' MRX-4 Combo Shows Positive Results in Phase III Study
CompanyDrug

MicuRx Pharmaceuticals’ MRX-4 Combo Shows Positive Results in Phase III Study

National Reimbursement Drug List 2024 Expands Coverage with 91 New Drugs
Policy / Regulatory

National Reimbursement Drug List 2024 Expands Coverage with 91 New Drugs

Allink Biotherapeutics Secures $42 Million in Series A Financing to Advance Bispecific Antibodies and ADCs
CompanyDeals

Allink Biotherapeutics Secures $42 Million in Series A Financing to Advance Bispecific Antibodies and ADCs

China's NHC Aims to Enhance Continuity of Medical Services with Referral System by 2030
Policy / Regulatory

China’s NHC Aims to Enhance Continuity of Medical Services with Referral System by 2030

Jiangsu Kanion Pharmaceutical Secures NMPA Approvals for KYHY2302 and KYHY2303
CompanyDrug

Jiangsu Kanion Pharmaceutical Secures NMPA Approvals for KYHY2302 and KYHY2303

NHSA Issues Guidelines to Suspend Direct Online Listing of In-Shortage Drugs
Policy / Regulatory

NHSA Issues Guidelines to Suspend Direct Online Listing of In-Shortage Drugs

BeiGene's Tevimbra Receives EC Approval for First-Line ESCC and G/GEJ Adenocarcinoma Treatments
CompanyDrug

BeiGene’s Tevimbra Receives EC Approval for First-Line ESCC and G/GEJ Adenocarcinoma Treatments

Fosun Pharmaceutical's Daxxify Receives NMPA Approval for Cervical Muscle Tone Disorders
CompanyDrug

Fosun Pharmaceutical’s Daxxify Receives NMPA Approval for Cervical Muscle Tone Disorders

Phil Rivers Technology Secures IND Approval for PR00012 from NMPA's CDE
CompanyDrug

Phil Rivers Technology Secures IND Approval for PR00012 from NMPA’s CDE

Hansoh Pharmaceutical's Ameile Receives NMPA Review for Fifth Indication in NSCLC Treatment
CompanyDrug

Hansoh Pharmaceutical’s Ameile Receives NMPA Review for Fifth Indication in NSCLC Treatment

China Medical System Holdings Gets NMPA Approval to Test Obesity Treatment CMS-D005
CompanyDrug

China Medical System Holdings Gets NMPA Approval to Test Obesity Treatment CMS-D005